Agenda 2023
Agenda - Friday, October 13, 2023
*Times listed are in Eastern Standard Time
6:45 - 7:20 AM |
Registration and Breakfast with Exhibits |
|
7:20 - 7:30 AM |
Welcome / Introductions / Opening Remarks |
|
Session I |
||
7:30 - 7:40 AM |
12-lead ECG: Targeting the Base of the SCD Iceberg with a Little Help from AI |
|
7:40 - 7:50 AM |
Sudden Cardiac Death and Cardiac Proteomics |
|
7:50 - 8:00 AM |
Polygenic Risk Scores as Risk-stratification Tools |
|
8:00 - 8:10 AM |
How to Assess Arrhythmia Risk in Patients with MVP |
|
8:10 - 8:20 AM |
Prediction of SCD in HCM |
|
8:20 - 8:30 AM |
Biomarkers for Sudden Death Risk Assessment |
|
8:30 - 8:50 AM |
Panel Discussion with Q&A Session |
|
Session II |
||
8:50 - 8:57 AM |
IVTCC 3.0 Update (VT Ablation Registry) |
|
8:57 - 9:04 AM |
LESS VT in NICM (ENDO–EPI VT Ablation Approval of TactiCath) |
|
9:04 - 9:11 AM |
SMART DEF Trial (RCT on Post-MI MRI-based ICD Implantation) |
|
9:11 - 9:18 AM |
RADIATE VT (SBRT After Catheter Ablation Failure) |
|
9:18 - 9:25 AM |
VELVET Trial (Venous Alcohol Ablation) |
|
9:25 - 9:32 AM |
STALL-VT (RCT on Transcutaneous Neuro Stimulation in VT Storm) |
|
9:32 - 9:39 AM |
PIVATAL Trial (Prophylactic VT Ablation at Time of LVAD Implant) Joshua Moss |
|
9:39 - 9:49 AM |
Commentary: Are We on the Right Track with Our Studies? Karl-Heinz Kuck |
|
9:49 - 10:10 AM |
Coffee Break (To Discuss Trials and Visit Exhibits) |
|
Session III |
||
10:10 - 10:20 AM |
VT and Repolarization Heterogeneity Within the Infarct Scar |
|
10:20 - 10:30 AM |
Frequency Analysis of Endocardial EgMs to Detect Intramural Fibrosis |
|
10:30 - 10:40 AM |
Characterization of VT Exit Sites: New Insights |
|
10:40 - 10:50 AM |
How to Evaluate the Full Substrate in VT Ablation: The Role of S2–S3 Maps |
|
10:50 - 11:00 AM |
Endocardial and Epicardial Ablation in All Post-MI VT Patients? |
|
11:00 - 11:20 AM |
Panel Discussion with Q&A Session |
|
11:20 - 11:30 AM |
Pick Up Lunch |
|
|
Session IV |
|
|
Session V |
|
1:30 - 1:40 PM |
Impact of Cardiac SBRT on Infarcted Myocardium |
|
1:40 - 1:50 PM |
Mechanism of Effect of Proton Beam Therapy |
|
1:50 - 2:00 PM |
Efficacy and Safety of SBRT |
|
2:00 - 2:10 PM |
Optimizing SBRT Targeting—Best EP Data + Radiation Delivery: Lessons Learned |
|
2:10 - 2:30 PM |
Panel Discussion with Q&A Session |
|
2:30 - 2:55 PM |
Coffee Break and Exhibits |
|
Session VI |
||
2:55 - 3:05 PM |
cMR Imaging of Conduction System Pacing |
|
3:05 - 3:15 PM |
Left Bundle Branch Area Pacing or Biventricular Pacing for CRT? |
|
3:15 - 3:25 PM |
Subcutaneous and Extravascular ICDs: The Future of ICD Therapy? |
|
3:25 - 3:35 PM |
Wearable Then Implantable Cardioverter Defibrillator Post-MI |
|
3:35 - 3:45 PM |
Cardiac Contractility Modulation: Versus or with Drug Therapy? |
|
3:45 - 4:55 PM |
Optimizing SQ ICD Implantation: Important Considerations Robert Schaller |
|
4:55 - 4:15 PM |
Panel Discussion with Q&A Session |
|
|
Session VII |
|
4:15 - 4:25 PM |
Biophysics of PFA in Scarred Myocardium |
|
4:25 - 4:35 PM |
How to Ensure Durable PFA Lesions |
|
4:35 - 4:45 PM |
Ventricular PFA: Benefits and Challenges |
|
4:45 - 4:55 PM |
Important Observations During PFA Application in the Ventricle |
|
4:55 - 5:05 PM |
PFA Effect on Coronaries: A Deep Dive Into Pathophysiology and Prevention |
|
5:05 - 5:15 PM |
Initial Clinical Experiences for VT Ablation |
|
5:15 - 5:40 PM |
Panel Discussion with Q&A Session |
|
Session VIII Pre-recorded Cases Highlighting New Concepts/Techniques 12 minute presentations/3 minute Q&A Moderators: Francis Marchlinski and David Callans |
||
5:40 - 5:55 PM |
LV Endocardial Access with Double Mechanical Valves |
|
5:55 - 6:10 PM |
CO2 Insufflation for Epicardial Access |
|
6:10 - 6:25 PM |
Large Footprint Multielectrode Ablation: RF vs PFA |
|
6:25 - 6:30 PM |
Day 1 Wrap-up |
|
6:30 - 7:30 PM |
Welcome Reception—All Attendees |